$TGTX

$57.10▲ 95.01% YTD

8 SEC 13D/G filings tracked · Last updated Oct 27, 2026

Filing History

TGTX - TG Therapeutics, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks Simplified

$57.10▲ 95.01%Oct 27, 2026 · ThinkSabio Blog

$TGTX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #TGTX TG Therapeutics, Inc. : $57.10 Sector: Healthcare | YTD: 🔼…

News

TGTX ▼ -1.5% - TG Therapeutics, Inc.

CP $52.38▲ -1.5%Oct 23, 2026 · ThinkSabio Blog

$TGTX - TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto…

News

TGTX ▼ -1.5% - TG Therapeutics, Inc.

CP $52.38▲ -1.5%Oct 23, 2026 · ThinkSabio Blog

$TGTX TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto20…

News

TGTX ▲ +0.5% - TG Therapeutics, Inc.

CP $54.81▲ +0.5%Oct 21, 2026 · ThinkSabio Blog

$TGTX - TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026…

News

TGTX ▼ -0.1% - TG Therapeutics, Inc.

CP $54.50▲ -0.1%Oct 21, 2026 · ThinkSabio Blog

$TGTX TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026…

News

TGTX ▼ -0.7% - TG Therapeutics, Inc.

CP $55.05▲ -0.7%Oct 12, 2026 · ThinkSabio Blog

$TGTX - TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Scl…

News

TGTX ▼ -0.7% - TG Therapeutics, Inc.

CP $55.05▲ -0.7%Oct 12, 2026 · ThinkSabio Blog

$TGTX TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Scler…

News

TGTX ▼ -0.0% - TG Therapeutics, Inc.

CP $52.94▲ -0.0%Oct 8, 2026 · ThinkSabio Blog

$TGTX - TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026…